You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Details for New Drug Application (NDA): 018803


✉ Email this page to a colleague

« Back to Dashboard


NDA 018803 describes SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER, which is a drug marketed by B Braun, Fresenius Kabi Usa, Fresenius Medcl, Haemonetics, Hospira, Icu Medical Inc, Laboratorios Grifols, Liebel-flarsheim, Abbott, Baxter Hlthcare, Jubilant Cadista, Miles, Nephron, and Taro, and is included in twenty-seven NDAs. It is available from twenty-one suppliers. Additional details are available on the SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER profile page.

The generic ingredient in SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER is sodium chloride. There are one thousand four hundred and seventy-two drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the sodium chloride profile page.
Summary for 018803
Tradename:SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
Applicant:Hospira
Ingredient:sodium chloride
Patents:0
Pharmacology for NDA: 018803
Suppliers and Packaging for NDA: 018803
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride SOLUTION;INJECTION 018803 NDA Henry Schein, Inc. 0404-9954 0404-9954-20 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9954-20) / 20 mL in 1 VIAL, SINGLE-DOSE
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER sodium chloride SOLUTION;INJECTION 018803 NDA Henry Schein, Inc. 0404-9954 0404-9954-50 1 VIAL, SINGLE-DOSE in 1 BAG (0404-9954-50) / 50 mL in 1 VIAL, SINGLE-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INJECTIONStrength90MG/10ML (9MG/ML)
Approval Date:Oct 29, 1982TE:APRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INJECTIONStrength180MG/20ML (9MG/ML)
Approval Date:Oct 29, 1982TE:APRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;INJECTIONStrength450MG/50ML (9MG/ML)
Approval Date:Oct 29, 1982TE:APRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.